ZA902378B - Cephalos porins and their homologues process for their preparation and pharmaceutical compositions - Google Patents
Cephalos porins and their homologues process for their preparation and pharmaceutical compositionsInfo
- Publication number
- ZA902378B ZA902378B ZA902378A ZA902378A ZA902378B ZA 902378 B ZA902378 B ZA 902378B ZA 902378 A ZA902378 A ZA 902378A ZA 902378 A ZA902378 A ZA 902378A ZA 902378 B ZA902378 B ZA 902378B
- Authority
- ZA
- South Africa
- Prior art keywords
- preparation
- cephalos
- porins
- homologues
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
- C07D463/16—Nitrogen atoms
- C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
- C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB898907171A GB8907171D0 (en) | 1989-03-30 | 1989-03-30 | Novel compounds |
GB898920791A GB8920791D0 (en) | 1989-09-14 | 1989-09-14 | Novel compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA902378B true ZA902378B (en) | 1991-06-26 |
Family
ID=26295148
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA902378A ZA902378B (en) | 1989-03-30 | 1990-03-28 | Cephalos porins and their homologues process for their preparation and pharmaceutical compositions |
Country Status (12)
Country | Link |
---|---|
US (1) | US5246926A (fr) |
EP (1) | EP0395219B1 (fr) |
JP (1) | JP2979235B2 (fr) |
KR (1) | KR900014403A (fr) |
AT (1) | ATE171705T1 (fr) |
AU (1) | AU625844B2 (fr) |
CA (1) | CA2013391A1 (fr) |
DE (1) | DE69032681T2 (fr) |
DK (1) | DK0395219T3 (fr) |
ES (1) | ES2121745T3 (fr) |
PT (1) | PT93602A (fr) |
ZA (1) | ZA902378B (fr) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5332731A (en) * | 1989-12-07 | 1994-07-26 | Meiji Seika Kaisha, Ltd. | Cephalosporin derivatives |
MY106399A (en) * | 1990-07-24 | 1995-05-30 | Pfizer | Cephalosporins and homologeus, preparation and pharmaceutical composition |
US6020329A (en) * | 1990-07-24 | 2000-02-01 | Pzifer Inc. | Cephaloporins and homologues, preparations and pharmaceutical compositions |
US6001997A (en) * | 1990-07-24 | 1999-12-14 | Bateson; John Hargreaves | Cephalosporins and homologues, preparations and pharmaceutical compositions |
GB9019743D0 (en) * | 1990-09-10 | 1990-10-24 | Beecham Group Plc | Novel compounds |
DE4037841A1 (de) * | 1990-11-28 | 1992-06-04 | Bayer Ag | Neue 3-substituierte cephalosporine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
IT1251643B (it) * | 1991-10-29 | 1995-05-17 | Mini Ricerca Scient Tecnolog | Derivati maleimmidici contenenti residui acrilici |
GB9125645D0 (en) * | 1991-12-03 | 1992-01-29 | Smithkline Beecham Plc | Novel compounds |
US5302711A (en) * | 1992-02-18 | 1994-04-12 | Eli Lilly And Company | Ester cleavage process for use with β-lactams |
GB9212609D0 (en) * | 1992-06-13 | 1992-07-29 | Smithkline Beecham Plc | Novel compounds |
GB9213567D0 (en) * | 1992-06-26 | 1992-08-12 | Smithkline Beecham Plc | Novel compounds |
US5604222A (en) | 1993-12-27 | 1997-02-18 | Lupin Laboratories, Ltd. | Method for the preparation of 2-chloro sulfinyl azetidinones |
US5578721A (en) | 1994-07-11 | 1996-11-26 | Lupin Laboratories Limited | Process for preparation of 3-exomethylene cepham sulfoxide esters |
GB9424847D0 (en) * | 1994-12-09 | 1995-02-08 | Smithkline Beecham Plc | Novel process |
IT1277048B1 (it) * | 1995-12-06 | 1997-11-04 | 3 Exo S R L | Procedimento per la preparazione di cefalosporine attraverso ciclizzazione riduttiva dicarbonilica per trattamento con |
EP1455900A1 (fr) * | 2001-12-21 | 2004-09-15 | Pfizer Products Inc. | Procedes de traitement d'infections bacteriennes chez les chats et les chiens |
US20040002600A1 (en) * | 2002-06-20 | 2004-01-01 | Orchid Chemicals And Pharmaceuticals Limited | Process for the conversion of penam ring system to cepham ring system |
MX2010003112A (es) * | 2007-09-21 | 2010-08-11 | Astrazeneca Ab | Formas de dosificacion solubles que contienen derivados de cephem adecuados para administracion parenteral. |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4868173A (en) * | 1984-11-20 | 1989-09-19 | Ici Pharma | Cephalosporin derivatives |
GB8821797D0 (en) * | 1988-09-16 | 1988-10-19 | Beecham Group Plc | Novel compounds |
-
1990
- 1990-03-26 ES ES90303177T patent/ES2121745T3/es not_active Expired - Lifetime
- 1990-03-26 DK DK90303177T patent/DK0395219T3/da active
- 1990-03-26 AT AT90303177T patent/ATE171705T1/de not_active IP Right Cessation
- 1990-03-26 EP EP90303177A patent/EP0395219B1/fr not_active Expired - Lifetime
- 1990-03-26 DE DE69032681T patent/DE69032681T2/de not_active Expired - Fee Related
- 1990-03-28 US US07/500,397 patent/US5246926A/en not_active Expired - Lifetime
- 1990-03-28 CA CA002013391A patent/CA2013391A1/fr not_active Abandoned
- 1990-03-28 AU AU52321/90A patent/AU625844B2/en not_active Ceased
- 1990-03-28 ZA ZA902378A patent/ZA902378B/xx unknown
- 1990-03-29 KR KR1019900004244A patent/KR900014403A/ko not_active Application Discontinuation
- 1990-03-29 PT PT93602A patent/PT93602A/pt not_active Application Discontinuation
- 1990-03-30 JP JP2081481A patent/JP2979235B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US5246926A (en) | 1993-09-21 |
JPH02286680A (ja) | 1990-11-26 |
DE69032681T2 (de) | 1999-02-25 |
EP0395219A2 (fr) | 1990-10-31 |
ES2121745T3 (es) | 1998-12-16 |
CA2013391A1 (fr) | 1990-09-30 |
DE69032681D1 (de) | 1998-11-05 |
EP0395219B1 (fr) | 1998-09-30 |
AU5232190A (en) | 1990-10-04 |
EP0395219A3 (fr) | 1992-04-01 |
DK0395219T3 (da) | 1999-02-15 |
JP2979235B2 (ja) | 1999-11-15 |
PT93602A (pt) | 1990-11-20 |
KR900014403A (ko) | 1990-10-23 |
AU625844B2 (en) | 1992-07-16 |
ATE171705T1 (de) | 1998-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA902378B (en) | Cephalos porins and their homologues process for their preparation and pharmaceutical compositions | |
HU906402D0 (en) | Process for producing tricyclic carbapeneme derivatives an pharmaceutical preparatives containing these compounds as active substance | |
HU9702474D0 (en) | Vinyl-pirrolidinone cephalosporins with basic substituents | |
EP0255908A3 (en) | 7-ûû3-(aminomethyl)-3-alkyl¨-1-pyrrolidinyl¨-quinoline-carboxylic acid-derivatives and pharmaceutical compositions containing them | |
EP0335297A3 (fr) | Dérivés de céphalosporine | |
AU1507888A (en) | New bicyclic compounds, processes for preparation thereof and pharmaceutical composition comprising the same | |
EP0359536A3 (fr) | Dérivés de céphalosporine, leur procédé de préparation et compositions pharmaceutiques | |
HUT57694A (en) | Process for producing new beta-diketones and pharmaceutical compositions comprising same | |
HU901570D0 (en) | Process for the preparation of azetidinyl-pyridonecarboxylic acid derivatives and pharmaceutical compositions containing such compounds | |
HUT60275A (en) | Process for producing 7-acyl-3-(substituted carbamoyloxy)-cef-3-em-4-carboxylic acid derivatives and pharmaceutical compositions comprising such compounds | |
AU608643B2 (en) | Novel derivatives of the oxime of 1,2,5,6-tetrahydropyridin-3-carboxaldehyde, the process for their preparation, their use as medicaments and the compositions containing them | |
ES8506731A1 (es) | Un procedimiento para preparar derivados de cefalosporina | |
AU636178B2 (en) | 7 (alanylaminothiazol-iminoacetamide) substituted cephalosporin derivatives | |
ATE212637T1 (de) | Anitbiotisch wirksame cephalosporine und verfahren zu ihrer herstellung | |
HK1003573A1 (en) | New antibiotics of the mureidomycin group their preparation and their therapeutic use | |
EP0354757A3 (fr) | Céphalosporines et produits homologues, leur procédé de préparation et compositions pharmaceutiques les contenant | |
GR3015422T3 (en) | Thiadiazolylacetamide cephem derivatives. |